Eversept Partners »

CVS Caremark Corporation shares owned by Eversept Partners

Quarter-by-quarter ownership of CVS Caremark Corporation (CVS) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in CVS Caremark Corporation

Tip: Access up to 7 years of quarterly data

All positions including CVS Caremark Corporation held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in CVS Caremark Corporation by Eversept Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.1M 64k 79.36

More positions owned by Eversept Partners

Vera Therapeutics Cl A (VERA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
GSK Sponsored Adr (GSK)
United Therapeutics Corporation (UTHR)
Abivax Sa Sponsored Ads (ABVX)
Natera (NTRA)
Syndax Pharmaceuticals (SNDX)
Miragen Therapeutics (VRDN)
Vaxcyte (PCVX)
Travere Therapeutics (TVTX)
Hca Holdings (HCA)
Danaher Corporation (DHR)
Ionis Pharmaceuticals (IONS)
Celldex Therapeutics Com New (CLDX)
Bruker Corporation (BRKR)

View all positions for Eversept Partners

Top funds holding CVS Caremark Corporation

BlackRock
Vanguard Group
Capital World Investors
Dodge & Cox
State Street Corporation
FMR
Jpmorgan Chase & Co
Geode Capital Management
Capital Research and Management Company - Division 3
Invesco
Norges Bank Investment Management
Pzena Investment Management
Citadel Advisors
Charles Schwab Investment Management
Davis Selected Advisers

View all funds holding CVS Caremark Corporation